USANA Health Sciences (NYSE:USNA) Director Sells $19,723.62 in Stock

USANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert Fuller sold 1,057 shares of the firm’s stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $18.66, for a total value of $19,723.62. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

USANA Health Sciences Price Performance

Shares of USNA stock opened at $18.90 on Friday. The firm has a market capitalization of $348.93 million, a price-to-earnings ratio of 40.22, a price-to-earnings-growth ratio of 0.74 and a beta of 0.77. The business has a fifty day moving average of $18.29 and a 200 day moving average of $19.47. USANA Health Sciences, Inc. has a 1 year low of $16.60 and a 1 year high of $38.32.

USANA Health Sciences (NYSE:USNA) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.44 by $0.17. The company had revenue of $250.22 million during the quarter, compared to analyst estimates of $240.99 million. USANA Health Sciences had a return on equity of 6.21% and a net margin of 0.96%.USANA Health Sciences has set its FY 2026 guidance at 1.950-2.290 EPS. As a group, equities research analysts expect that USANA Health Sciences, Inc. will post 2.12 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. National Bank of Canada FI lifted its holdings in USANA Health Sciences by 166.6% in the third quarter. National Bank of Canada FI now owns 1,922 shares of the company’s stock valued at $53,000 after acquiring an additional 1,201 shares during the period. Tower Research Capital LLC TRC increased its stake in shares of USANA Health Sciences by 382.5% in the 2nd quarter. Tower Research Capital LLC TRC now owns 2,398 shares of the company’s stock valued at $73,000 after purchasing an additional 1,901 shares in the last quarter. State of Wyoming purchased a new position in shares of USANA Health Sciences in the 1st quarter valued at about $57,000. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of USANA Health Sciences by 52.9% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,834 shares of the company’s stock valued at $106,000 after purchasing an additional 1,327 shares in the last quarter. Finally, Parallel Advisors LLC increased its stake in shares of USANA Health Sciences by 1,354.3% in the 4th quarter. Parallel Advisors LLC now owns 3,854 shares of the company’s stock valued at $76,000 after purchasing an additional 3,589 shares in the last quarter. 54.25% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on USNA shares. Wall Street Zen lowered USANA Health Sciences from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Weiss Ratings reiterated a “sell (d)” rating on shares of USANA Health Sciences in a research note on Friday, March 27th. Finally, Zacks Research lowered USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 22nd. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Reduce”.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc is a Utah‐based company that develops, manufactures and distributes nutritional supplements and personal care products through a network of independent distributors. Founded in 1992 by Dr. Myron Wentz, the company’s portfolio includes vitamins, minerals, dietary supplements, weight‐management products and skin‐care formulations. USANA’s products are formulated in its own laboratories to meet pharmaceutical‐grade standards, and the company has invested heavily in research and development and quality control to support its offerings.

Operating primarily through a direct selling model, USANA serves markets in North America, Asia Pacific, Europe and Latin America.